Effects of vitamin K2 in hemodialysis patients with low serum parathyroid hormone levels

Bone

Volumn 34, Issue 3, 2004, Pages 579-583

  Nakashima, Ayumu ^a   Yorioka, Noriaki ^b   Doi, Shigehiro ^a   Masaki, Takao ^b   Ito, Takafumi ^b   Harada, Satoru ^a  

^a Harada Hospital   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Bone markers; Bone turnover; Osteoporosis treatment; Renal osteodystrophy

Indexed keywords

4 CARBOXYGLUTAMIC ACID; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALKALINE PHOSPHATASE BONE ISOENZYME; AMINO TERMINAL TELOPEPTIDE; CALCIUM; COLLAGEN TYPE 1; MENATETRENONE; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHATE; FARNOQUINONE;

ADULT; ARTICLE; BONE METABOLISM; BONE REMODELING; BONE TURNOVER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEMODIALYSIS; HUMAN; HYPOPARATHYROIDISM; MALE; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; TREATMENT OUTCOME; AGED; BLOOD; COMPARATIVE STUDY; DRUG ANTAGONISM; MIDDLE AGED; NONPARAMETRIC TEST; PHYSIOLOGY; RENAL REPLACEMENT THERAPY;

ADULT; AGED; BONE REMODELING; FEMALE; HUMANS; MALE; MIDDLE AGED; PARATHYROID HORMONE; RENAL DIALYSIS; STATISTICS, NONPARAMETRIC; VITAMIN K 2;

EID: 1542376072     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2003.11.016     Document Type: Article

References (23)

1. Coco M., Rush H. Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am. J. Kidney Dis. 36:2000;1115-1121.
2. Kurz P., Monier-Faugere M.C., Bogner B., Werner E., Roth P., Vlachojannis J.et al. Evidence for abnormal calcium homeostasis in patients with adynamic bone disease. Kidney Int. 46:1994;855-861.
3. Goodman W.G., Goldin J., Kuizon B.D., Yoon C., Gales B., Sider D.et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N. Engl. J. Med. 342:2000;1478-1483.
4. Gerakis A., Hutchison A.J., Apostolou T., Freemont A.J., Billis A. Biochemical markers for non-invasive diagnosis of hyperparathyroid bone disease and adynamic bone in patients on haemodialysis. Nephrol. Dial. Transplant. 11:1996;2430-2438.
5. Hutchison A.J., Whitehouse R.W., Boulton H.F., Adams J.E., Mawer E.B., Freemont T.J.et al. Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease. Kidney Int. 44:1993;1071-1077.
6. Torres A., Lorenzo V., Hernandez D., Rodriguez J.C., Concepcion M.T., Rodriguez A.P.et al. Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH. Kidney Int. 47:1995;1434-1442.
7. Hauschka P.V., Lian J.B., Gallop P.M. Direct identification of the calcium-binding amino acid, gamma-carboxyglutamate, in mineralized tissue. Proc. Natl. Acad Sci. U. S. A. 72:1975;3925-3929.
8. Shiraki M., Shiraki Y., Aoki C., Miura M. Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J. Bone Miner. Res. 15:2000;515-521.
9. Iwasaki Y., Yamato H., Murayama H., Sato M., Takahashi T., Ezawa I.et al. Combination use of vitamin K(2) further increases bone volume and ameliorates extremely low turnover bone induced by bisphosphonate therapy in tail-suspension rats. J. Bone Miner. Metab. 21:2003;154-160.
10. Kohlmeier M., Saupe J., Shearer M.J., Schaefer K., Asmus G. Bone health of adult hemodialysis patients is related to vitamin K status. Kidney Int. 51:1997;1218-1221.
11. Shino M. Determination of endogenous vitamin K (phylloquinone and menaquinone-n) in plasma by high-performance liquid chromatography using platinum oxide catalyst reduction and fluorescence detection. Analyst. 113:1988;393-397.
12. Akedo Y., Hosoi T., Inoue S., Ikegami A., Mizuno Y., Kaneki M.et al. Vitamin K2 modulates proliferation and function of osteoblastic cells in vivo. Biochem. Biophys. Res. Commun. 187:1992;814-820.
13. Melkko J., Niemi S., Risteli L., Risteli J. Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clin. Chem. 36:1990;1328-1332.
14. Kameda T., Miyazawa K., Mori Y., Yuasa T., Shiokawa M., Nakamaru Y.et al. Vitamin K2 inhibits osteoclastic bone resorption by inducing osteoclast apoptosis. Biochem. Biophys. Res. Commun. 220:1996;515-519.
15. Hara K., Akiyama Y., Nakamura T., Murota S., Morita I. The inhibitory effects of vitamin K2 (menatetrenone) on bone resorption may be related to its side chain. Bone. 16:1995;179-184.
16. Chenu C., Colucci S., Grano M., Zigrino P., Barattolo R., Zambonin G.et al. Osteocalcin induces chemotaxis, secretion of matrix proteins, and calcium-mediated intracellular signaling in human osteoclast-like cells. J. Cell Biol. 127:1994;1149-1158.
17. Serre C.M., Price P., Delmas P.D. Degradation of subcutaneous implants of bone particles from normal and warfarin treated rats. J. Bone Miner. Res. 10:1995;1158-1167.
18. Brehme C.S., Roman S., Shaffer J., Wolfert R. Tartrate-resistant acid phosphatase forms complexes with alpha2-macroglobulin in serum. J. Bone Miner. Res. 4:1999;311-318.
19. Garnero P., Borel O., Byrjalsen I., Ferreras M., Drake F.H., McQueney M.S.et al. The collagenolytic activity of cathepsin K is unique among mammalian proteinases. J. Biol. Chem. 274:1998;32347-32352.
20. Nishi Y., Atley L., Eyre D.E., Edelson J.G., Supepti-Furga A., Yasuda T.et al. Determination of bone markers in pycnodysostosis: effects of cathepsin K deficiency of bone matrix degradation. J. Bone Miner. Res. 14:1999;1902-1908.
21. Eastell R., Mallinak N., Weiss S., Ettinger M., Pettinger M., Cain D.et al. Biological variability of serum and urinary N-telopeptides of type I collagen in postmenopausal women. J. Bone Miner. Res. 15:2000;594-598.
22. Montagnani A., Gonnelli S., Cepollaro C., Mangeri M., Martini S., Franci M.B.et al. A new serum assay to measure N-terminal fragment of telopeptide of type I collagen in patients with renal osteodystrophy. Eur. J. Intern. Med. 14:2003;172-177.
23. 2 (menaquinone 4) reduces serum undercarboxylated osteocalcin level as early as 2 weeks in elderly women with established osteoporosis. J. Bone Miner. Metab. 21:2003;161-165.